Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis
Daniel R. Altmann(London School of Hygiene & Tropical Medicine), D. H. Miller(Pacific Environment), Bas Jasperse(Vrije Universiteit Amsterdam), K. Wagner(University of London), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Alan J. Thompson(Queen Mary University of London), K. Beckmann(Ophthalmology Clinic), Tarek Yousry(National Hospital for Neurology and Neurosurgery), P. D. Molyneux(UCL Australia), L. D. Kappos(University of London), Chris H. Polman(Vrije Universiteit Amsterdam), Carlo Pozzilli(Sapienza University of Rome), Massimo Filippi(Vita-Salute San Raffaele University)
Cited by 100
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k